Skip Navigation


Brain Advance Access originally published online on May 18, 2005
Brain 2005 128(9):2016-2025; doi:10.1093/brain/awh543
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
128/9/2016    most recent
awh543v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Warren, J. D.
Right arrow Articles by Rossor, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warren, J. D.
Right arrow Articles by Rossor, M. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Brain biopsy in dementia

J. D. Warren1, J. M. Schott1, N. C. Fox1, M. Thom2, T. Revesz2,3, J. L. Holton2,3, F. Scaravilli2, D. G. T. Thomas4, G. T. Plant5, P. Rudge5 and M. N. Rossor1,5

1 Dementia Research Centre, 2 Division of Neuropathology, 3 Queen Square Brain Bank, Department of Molecular Neuroscience and 4 Division of Neurosurgery, Institute of Neurology and 5 National Hospital for Neurology and Neurosurgery, London, UK

Correspondence to: Dr J. Warren, Dementia Research Centre, Institute of Neurology, University College London, 8–11 Queen Square, London WC1N 3BG, UK E-mail: jwarren{at}dementia.ion.ucl.ac.uk

Brain biopsy has an uncertain role in the diagnosis of dementia. Here we report a retrospective analysis of 90 consecutive cerebral biopsies undertaken for the investigation of dementia in adults at a tertiary referral centre between 1989 and 2003. In most cases (90%), biopsy consisted of a right frontal full thickness resection of cortex, white matter and overlying leptomeninges. Fifty-seven per cent of biopsies were diagnostic: the most frequent diagnoses were Alzheimer's disease (18%), Creutzfeldt–Jakob disease (12%) and inflammatory disorders (9%). Other diagnoses in individual patients included Pick's disease, corticobasal degeneration and other tauopathies, Lewy body dementia, multiple sclerosis, Whipple's disease, progressive multifocal leucoencephalopathy, cerebral autosomal dominant arteriopathy with subcortical ischaemic leucoencephalopathy, vasculopathies and paraneoplastic encephalopathy. The most frequent biopsy finding in the non-diagnostic group and for the series as a whole (37%) was non-specific gliosis variably affecting both cortex and white matter. Complications (11%) included seizures, intracranial and wound infections, and intracranial haemorrhage; there were no deaths or lasting neurological sequelae attributable to the procedure. No trends in diagnostic yield or complication rate over the course of the series were identified. Information obtained at biopsy determined treatment in 11%. A raised cerebrospinal fluid cell count was the only robust predictor of a potentially treatable (inflammatory) process at biopsy. The constellation of behavioural change, raised CSF protein and matched oligoclonal bands in CSF and serum was associated with non-specific gliosis at biopsy. This series underlines the value of cerebral biopsy in the diagnosis of dementia, and suggests that certain clinical and laboratory features may be useful in guiding the decision to proceed to brain biopsy where a treatable disease cannot be excluded by other means.

Key Words: brain biopsy; dementia; Alzheimer's disease; non-specific gliosis

Abbreviations: CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy; CJD = Creutzfeldt–Jakob disease

Received February 1, 2005. Revised April 19, 2005. Accepted April 21, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
B. J. Kelley, B. F. Boeve, and K. A. Josephs
Young-Onset Dementia: Demographic and Etiologic Characteristics of 235 Patients
Arch Neurol, November 1, 2008; 65(11): 1502 - 1508.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. M. Keegan, C. Giannini, J. E. Parisi, C. F. Lucchinetti, B. F. Boeve, and K. A. Josephs
Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS
Neurology, March 25, 2008; 70(13_Part_2): 1128 - 1133.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Mead, T. E. F. Webb, T. A. Campbell, J. Beck, J. M. Linehan, S. Rutherfoord, S. Joiner, J. D. F. Wadsworth, J. Heckmann, S. Wroe, et al.
Inherited prion disease with 5-OPRI: Phenotype modification by repeat length and codon 129
Neurology, August 21, 2007; 69(8): 730 - 738.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. T. Hu, J. A. Murray, M. C. Greenaway, J. E. Parisi, and K. A. Josephs
Cognitive impairment and celiac disease.
Arch Neurol, October 1, 2006; 63(10): 1440 - 1446.
[Abstract] [Full Text] [PDF]


Home page
PNHome page
J. M Schott
Limbic encephalitis: a clinician's guide
Practical Neurology, June 1, 2006; 6(3): 143 - 153.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.